The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2019

Filed:

Mar. 21, 2019
Applicant:

Soonchunhyang University Industry Academy Cooperation Foundation, Asan-si, Chungcheongnam-do, KR;

Inventors:

Jungkyun Im, Asan-si, KR;

Goutam Biswas, Delhi, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A23L 33/10 (2016.01); A61K 31/165 (2006.01); A61K 49/00 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 25/16 (2006.01); A61K 31/155 (2006.01); A61K 31/16 (2006.01); A61K 31/352 (2006.01); C07D 311/86 (2006.01);
U.S. Cl.
CPC ...
A61K 31/165 (2013.01); A23L 33/10 (2016.08); A61K 31/155 (2013.01); A61K 31/16 (2013.01); A61K 31/352 (2013.01); A61K 49/0041 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); A61P 29/00 (2018.01); C07D 311/86 (2013.01); A23V 2002/00 (2013.01); A23V 2200/322 (2013.01);
Abstract

The present invention relates to an ibuprofen conjugate in which ibuprofen (S-(+)-ibuprofen) is covalently linked to a guanidine-terminal-group-bound sugar alcohol derivative and to a pharmaceutical composition containing the same. The ibuprofen conjugate in which ibuprofen is covalently linked to a guanidine-terminal-group-bound sugar alcohol derivative can more effectively penetrate into the brain by passing through the blood-brain barrier (BBB), thus enabling efficient drug delivery to the brain, whereby administration of the ibuprofen conjugate in an optimal dose can minimize side effects of nonsteroidal anti-inflammatory drugs (NSAIDs) and can prevent or treat degenerative brain disease.


Find Patent Forward Citations

Loading…